Attovia Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 15.19 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 693.44M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Attovia Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops biotherapeutics for immune-mediated diseases in the United States. The company provides ATTOBODY, a biparatopic biologics platform designed to deliver improved treatments. The company’s products include ATTO-1310, a novel ATTOBODY-based Fc-fusion protein therapeutic that inhibits IL-31; developed for the treatment of chronic pruritic diseases such as CPUO, high-itch AD, cholestatic pruritus, and CKD-aP; ATTO-2306, an ATTOBODY-based, half-life-extended immunoglobuli...